サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1404660

高分子バイオ分析技術の市場規模、シェア、動向分析レポート：製品・サービス別、用途別、地域別、セグメント予測、2023年～2030年

Large Molecule Bioanalytical Technologies Market Size, Share & Trends Analysis Report By Products & Services, By Application (Biologics, Cell & Gene Therapy), By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 258 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
高分子バイオ分析技術の市場規模、シェア、動向分析レポート：製品・サービス別、用途別、地域別、セグメント予測、2023年～2030年
出版日: 2023年11月13日
発行: Grand View Research
ページ情報: 英文 258 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

高分子バイオ分析技術市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の高分子バイオ分析技術市場規模は、予測期間中に10.5%のCAGRを記録し、2030年までに167億6,000万米ドルに達すると予測されています。

バイオ分析検査サービスに対する需要は過去数年間で大幅に増加しており、市場の成長にプラスの影響を与えています。

これは主に、バイオ医薬品業界における研究開発活動の拡大が、この分野への注目すべき投資につながっているためです。また、現在進行中のCOVID-19の大流行により、主要利害関係者の製造・研究開発能力が拡大し、生物分析試験サービスの需要増につながっています。ワクチンと細胞遺伝子治療の開発における先端技術の利用は、この分野の著しい成長につながった。

装置の進歩は、受託製造業者にとって有利な機会を生み出しています。ここ数年、バイオ医薬品メーカーはバイオ製造活動の少なくとも一部をアウトソーシングしています。分析試験は、アッセイを実施するために高度に専門化された人員と機器を必要とするため、最もアウトソーシングされている活動の1つです。これらの要因は、市場成長の形成に重要な役割を果たすと予想されます。

高分子バイオ分析技術市場レポートハイライト

  • 2022年の収益シェアは製品分野が最大。
  • バイオ医薬品は、特性評価、同定、純度、力価試験にさまざまな機器を必要とします。
  • 前述のアッセイアプリケーションのための幅広い製品が入手可能であることが、セグメント成長の主な要因です。
  • 生物製剤は、このセグメントにおける研究開発活動プログラムの継続的な拡大により、2022年の主要収益シェアを占めました。
  • また、先端治療に対する厳しい規制の枠組みが存在することで、バイオ分析検査サービスの需要が高まっています。
  • COVID-19パンデミックは、遺伝子ワクチンの開発を加速させています。
  • これにより、高分子の安全性と安定性を評価するための分析ツールの有用性が高まり、同分野を牽引しています。
  • 北米は、バイオ医薬品製造の商業基盤だけでなく、強力な研究基盤が存在するため、2022年の市場を独占しました。
  • さらに、米国は最大のバイオ医薬品市場であり、同地域における高分子バイオ分析技術の採用と利用にプラスの影響を与えています。
  • アジア太平洋では、中国や日本などの新興市場が最前線にあり、市場は最も速いCAGRを記録すると推定されます。
  • バイオ製造能力の拡大を目的とした国内企業と世界企業との協力関係が、この地域の市場成長を補完しています。
  • 主要企業は、市場での地位を維持するために新製品の上市に注力しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 高分子バイオ分析技術市場の変数、動向および範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 高分子バイオ分析技術市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 高分子バイオ分析技術市場：製品およびサービスの推定・動向分析

  • 高分子バイオ分析技術市場：重要なポイント
  • 高分子バイオ分析技術市場：製品とサービスの変動と市場シェア分析、2022年と2030年
  • 製品
  • サービス

第5章 高分子バイオ分析技術市場：用途の推定・動向分析

  • 高分子バイオ分析技術市場：重要なポイント
  • 高分子バイオ分析技術市場：用途の変動と市場シェア分析、2022年および2030年
  • 生物製剤
  • オリゴヌクレオチド由来の薬物および分子
  • ウイルスベクター
  • 細胞および遺伝子治療
  • ナノ粒子とポリマー

第6章 高分子バイオ分析技術市場：地域の推定・動向分析

  • 地域別の見通し
  • 地域別の高分子バイオ分析技術市場：市場の重要なマーケットプレース
  • 北米
    • 市場推計・予測、2018～2030年
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 市場参入企業の分類
    • Intertek Group plc
    • SOLVIAS AG
    • Bio-Techne Corporation
    • Wyatt Technology Corporation
    • Precision NanoSystems
    • Verder
    • Halo Labs
    • Charles River Laboratories International, Inc.
    • Avomeen
    • Merck KGaA
    • Cergentis B.V.
    • Laboratory Corporation of America Holdings
    • SCIEX
    • F. Hoffmann-La Roche AG
    • Bio-Rad Laboratories, Inc.
図表

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America large molecule bioanalytical technologies market, by product & service, 2018 - 2030 (USD Million)
  • Table 3 North America large molecule bioanalytical technologies market, by application, 2018 - 2030 (USD Million)
  • Table 4 North America large molecule bioanalytical technologies market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. large molecule bioanalytical technologies market, by product & service, 2018 - 2030 (USD Million)
  • Table 6 U.S. large molecule bioanalytical technologies market, by application, 2018 - 2030 (USD Million)
  • Table 7 Canada large molecule bioanalytical technologies market, by product & service, 2018 - 2030 (USD Million)
  • Table 8 Canada large molecule bioanalytical technologies market, by application, 2018 - 2030 (USD Million)
  • Table 9 Europe large molecule bioanalytical technologies market, by product & service, 2018 - 2030 (USD Million)
  • Table 10 Europe large molecule bioanalytical technologies market, by application, 2018 - 2030 (USD Million)
  • Table 11 Europe large molecule bioanalytical technologies market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany large molecule bioanalytical technologies market, by product & service, 2018 - 2030 (USD Million)
  • Table 13 Germany large molecule bioanalytical technologies market, by application, 2018 - 2030 (USD Million)
  • Table 14 UK large molecule bioanalytical technologies market, by product & service, 2018 - 2030 (USD Million)
  • Table 15 UK large molecule bioanalytical technologies market, by application, 2018 - 2030 (USD Million)
  • Table 16 France large molecule bioanalytical technologies market, by product & service, 2018 - 2030 (USD Million)
  • Table 17 France large molecule bioanalytical technologies market, by application, 2018 - 2030 (USD Million)
  • Table 18 Italy large molecule bioanalytical technologies market, by product & service, 2018 - 2030 (USD Million)
  • Table 19 Italy large molecule bioanalytical technologies market, by application, 2018 - 2030 (USD Million)
  • Table 20 Spain large molecule bioanalytical technologies market, by product & service, 2018 - 2030 (USD Million)
  • Table 21 Spain large molecule bioanalytical technologies market, by application, 2018 - 2030 (USD Million)
  • Table 22 Sweden large molecule bioanalytical technologies market, by product & service, 2018 - 2030 (USD Million)
  • Table 23 Sweden large molecule bioanalytical technologies market, by application, 2018 - 2030 (USD Million)
  • Table 24 Norway large molecule bioanalytical technologies market, by product & service, 2018 - 2030 (USD Million)
  • Table 25 Norway large molecule bioanalytical technologies market, by application, 2018 - 2030 (USD Million)
  • Table 26 Denmark large molecule bioanalytical technologies market, by product & service, 2018 - 2030 (USD Million)
  • Table 27 Denmark large molecule bioanalytical technologies market, by application, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific large molecule bioanalytical technologies market, by product & service, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific large molecule bioanalytical technologies market, by application, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific large molecule bioanalytical technologies market, by region, 2018 - 2030 (USD Million)
  • Table 31 China large molecule bioanalytical technologies market, by product & service, 2018 - 2030 (USD Million)
  • Table 32 China large molecule bioanalytical technologies market, by application, 2018 - 2030 (USD Million)
  • Table 33 Japan large molecule bioanalytical technologies market, by product & service, 2018 - 2030 (USD Million)
  • Table 34 Japan large molecule bioanalytical technologies market, by application, 2018 - 2030 (USD Million)
  • Table 35 India large molecule bioanalytical technologies market, by product & service, 2018 - 2030 (USD Million)
  • Table 36 India large molecule bioanalytical technologies market, by application, 2018 - 2030 (USD Million)
  • Table 37 Australia large molecule bioanalytical technologies market, by product & service, 2018 - 2030 (USD Million)
  • Table 38 Australia large molecule bioanalytical technologies market, by application, 2018 - 2030 (USD Million)
  • Table 39 Thailand large molecule bioanalytical technologies market, by product & service, 2018 - 2030 (USD Million)
  • Table 40 Thailand large molecule bioanalytical technologies market, by application, 2018 - 2030 (USD Million)
  • Table 41 South Korea large molecule bioanalytical technologies market, by product & service, 2018 - 2030 (USD Million)
  • Table 42 South Korea large molecule bioanalytical technologies market, by application, 2018 - 2030 (USD Million)
  • Table 43 Latin America large molecule bioanalytical technologies market, by product & service, 2018 - 2030 (USD Million)
  • Table 44 Latin America large molecule bioanalytical technologies market, by application, 2018 - 2030 (USD Million)
  • Table 45 Latin America large molecule bioanalytical technologies market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil large molecule bioanalytical technologies market, by product & service, 2018 - 2030 (USD Million)
  • Table 47 Brazil large molecule bioanalytical technologies market, by application, 2018 - 2030 (USD Million)
  • Table 48 Mexico large molecule bioanalytical technologies market, by product & service, 2018 - 2030 (USD Million)
  • Table 49 Mexico large molecule bioanalytical technologies market, by application, 2018 - 2030 (USD Million)
  • Table 50 Argentina large molecule bioanalytical technologies market, by product & service, 2018 - 2030 (USD Million)
  • Table 51 Argentina large molecule bioanalytical technologies market, by application, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa large molecule bioanalytical technologies market, by product & service, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa large molecule bioanalytical technologies market, by application, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa large molecule bioanalytical technologies market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa large molecule bioanalytical technologies market, by product & service, 2018 - 2030 (USD Million)
  • Table 56 South Africa large molecule bioanalytical technologies market, by application, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia large molecule bioanalytical technologies market, by product & service, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia large molecule bioanalytical technologies market, by application, 2018 - 2030 (USD Million)
  • Table 59 UAE large molecule bioanalytical technologies market, by product & service, 2018 - 2030 (USD Million)
  • Table 60 UAE large molecule bioanalytical technologies market, by application, 2018 - 2030 (USD Million)
  • Table 61 Kuwait large molecule bioanalytical technologies market, by product & service, 2018 - 2030 (USD Million)
  • Table 62 Kuwait large molecule bioanalytical technologies market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Large molecule bioanalytical technologies: market outlook
  • Fig. 9 Large molecule bioanalytical technologies competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Large molecule bioanalytical technologies market driver impact
  • Fig. 15 Large molecule bioanalytical technologies market restraint impact
  • Fig. 16 Large molecule bioanalytical technologies market strategic initiatives analysis
  • Fig. 17 Large molecule bioanalytical technologies market: Product & Service movement analysis
  • Fig. 18 Large molecule bioanalytical technologies market: Product & Service outlook and key takeaways
  • Fig. 19 Product market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Service market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Large molecule bioanalytical technologies market: Application movement analysis
  • Fig. 22 Large molecule bioanalytical technologies market: Application outlook and key takeaways
  • Fig. 23 Biologics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Oligonucleotide Derived Drugs & Molecules market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Viral Vector market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Cell & Gene Therapy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Nanoparticles & Polymers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Global large molecule bioanalytical technologies market: Regional movement analysis
  • Fig. 29 Global large molecule bioanalytical technologies market: Regional outlook and key takeaways
  • Fig. 30 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68039-425-9

Large Molecule Bioanalytical Technologies Market Growth & Trends:

The global large molecule bioanalytical technologies market size is expected to reach USD 16.76 billion by 2030, registering a CAGR of 10.5% during the forecast period, according to a new report by Grand View Research, Inc. The demand for bioanalytical testing services has significantly increased over the past few years, thereby positively impacting the growth of the market.

This is primarily due to the growing R&D activities in the biopharmaceutical industry, leading to notable investments in the space. Also, the ongoing pandemic of COVID-19 has resulted in the expansion of manufacturing and R&D capabilities of key stakeholders leading to increased demand for bioanalytical testing services. The use of advanced technologies in vaccine and cell gene therapy development has led to significant growth of this space.

Advancements in instrumentation have created lucrative opportunities for contract manufacturers. Over the past several years, biopharmaceutical manufacturers are outsourcing at least some part of their biomanufacturing activities. Analytical testing is one of the most outsourced activities as it requires highly specialized personnel and equipment to conduct assays. These factors are anticipated to play a vital role in shaping market growth.

Large Molecule Bioanalytical Technologies Market Report Highlights:

  • The product segment accounted for the largest revenue share in 2022
  • Biopharmaceutical products require various instruments for characterization, identification, purity, and potency testing
  • Availability of a wide range of products for the aforementioned assay applications is the key factor contributing to segment growth
  • Biologics accounted for the major revenue share in 2022 owing to the ever-expanding R&D activity programs in the segment
  • Besides, the presence of a stringent regulatory framework for advanced therapies has increased the demand for bioanalytical testing services
  • The COVID-19 pandemic has accelerated the development of genetic vaccines
  • This increases the utility of analytical tools for assessing the safety and stability of large molecules, thereby driving the segment
  • North America dominated the market in 2022 owing to the presence of strong research as well as a commercial base for biopharmaceutical manufacturing
  • Moreover, the U.S. is the largest biopharmaceutical market that has positively influenced the adoption and usage of large molecule bioanalytical technologies in the region
  • In the Asia Pacific, the market is estimated to register the fastest CAGR with emerging markets such as China and Japan at the forefront
  • Collaborations between domestic and global players for expansion of biomanufacturing capabilities are supplementing the growth of the market in the region
  • Key companies are focusing on new product launches to sustain their position in the market.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product & Service
    • 1.1.2. Application
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product & service outlook
    • 2.2.2. Application outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Large Molecule Bioanalytical Technologies Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. Large Molecule Bioanalytical Technologies Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's Five Forces
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic Landscape

Chapter 4. Large Molecule Bioanalytical Technologies Market: Product & Service Estimates & Trend Analysis

  • 4.1. Large Molecule Bioanalytical Technologies Market: Key Takeaways
  • 4.2. Large Molecule Bioanalytical Technologies Market: Product & Service Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Product
    • 4.3.1. Product market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Service
    • 4.4.1. Service market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Large Molecule Bioanalytical Technologies Market: Application Estimates & Trend Analysis

  • 5.1. Large Molecule Bioanalytical Technologies Market: Key Takeaways
  • 5.2. Large Molecule Bioanalytical Technologies Market: Application Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Biologics
    • 5.3.1. Biologics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Oligonucleotide Derived Drugs & Molecules
    • 5.4.1. Oligonucleotide derived drugs & molecules market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Viral Vector
    • 5.5.1. Viral vector market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Cell & Gene Therapy
    • 5.6.1. Cell & gene therapy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Nanoparticles & Polymers
    • 5.7.1. Nanoparticles & polymers market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Large Molecule Bioanalytical Technologies Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Large Molecule Bioanalytical Technologies Market by Region: Key Marketplace Takeaways
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. Intertek Group plc
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. SOLVIAS AG
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Bio-Techne Corporation
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Wyatt Technology Corporation
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Precision NanoSystems
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Verder
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Halo Labs
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Charles River Laboratories International, Inc.
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. Avomeen
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. Merck KGaA
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives
    • 7.2.11. Cergentis B.V.
      • 7.2.11.1. Company overview
      • 7.2.11.2. Financial performance
      • 7.2.11.3. Product benchmarking
      • 7.2.11.4. Strategic initiatives
    • 7.2.12. Laboratory Corporation of America Holdings
      • 7.2.12.1. Company overview
      • 7.2.12.2. Financial performance
      • 7.2.12.3. Product benchmarking
      • 7.2.12.4. Strategic initiatives
    • 7.2.13. SCIEX
      • 7.2.13.1. Company overview
      • 7.2.13.2. Financial performance
      • 7.2.13.3. Product benchmarking
      • 7.2.13.4. Strategic initiatives
    • 7.2.14. F. Hoffmann-La Roche AG
      • 7.2.14.1. Company overview
      • 7.2.14.2. Financial performance
      • 7.2.14.3. Product benchmarking
      • 7.2.14.4. Strategic initiatives
    • 7.2.15. Bio-Rad Laboratories, Inc.
      • 7.2.15.1. Company overview
      • 7.2.15.2. Financial performance
      • 7.2.15.3. Product benchmarking
      • 7.2.15.4. Strategic initiatives